Macrogol 4000 Viatris

Macrogol 4000, the active ingredient in Macrogol 4000 Viatris, is an osmotic laxative presented as an oral powder for solution for oral use. It is used to relieve constipation and to prepare the bowel for diagnostic procedures in adults and children. GNH USA supplies Macrogol 4000 Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Macrogol 4000 is an osmotic laxative that works within the gastrointestinal tract to increase water content in stool. - Constipation: softens stool and promotes regular bowel movements. - Bowel preparation for colonoscopy: cleans the colon by inducing watery stools. - Chronic idiopathic constipation: improves stool frequency and consistency in long‑term cases. - Fecal impaction: facilitates evacuation of hardened stool.

Macrogol 4000 may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Diarrhea - Abdominal cramps - Headache

Serious or Rare Side Effects: - Severe electrolyte imbalance - Allergic reaction (rash, itching, swelling) - Severe abdominal pain - Dehydration - Intestinal obstruction - Renal impairment

When using Macrogol 4000, certain safety considerations should be observed. - Renal function assessment: evaluate kidney status before initiating therapy. - Electrolyte monitoring: check serum electrolytes in patients at risk of imbalance. - Bowel obstruction: avoid use in known or suspected mechanical obstruction. - Hypersensitivity: discontinue if allergic signs appear. - Elderly patients: start with the lowest effective dose and monitor tolerance. - Store at ambient temperature: keep in the original container, protect from moisture.

Macrogol 4000 can interact with other medications that affect fluid balance or gastrointestinal motility.

Major Interactions (Avoid): - Concurrent use with other osmotic laxatives (e.g., sodium phosphate) may cause excessive fluid loss. - Combination with loop diuretics can exacerbate electrolyte disturbances. - Co‑administration with high‑dose magnesium salts may lead to additive osmotic effects.

Moderate Interactions (Monitor Closely): - Opioid analgesics may reduce laxative efficacy. - Anticholinergic agents could diminish gastrointestinal motility. - Medications requiring stable intestinal pH (e.g., certain antibiotics) may have altered absorption.